Osage University Partners III LP 13D and 13G filings for Satsuma Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2020-12-04 5:12 pm Sale |
2020-09-11 | 13G | Satsuma Pharmaceuticals, Inc. STSA |
Osage University Partners III LP | 0 0.000% |
-935,058![]() (Position Closed) |
Filing |